← Leaderboards
Roger Packer
Children'S Research Institute
$5,643,404
Attributed
$7,061,602
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $977.9K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$6,714,841 · 9
FDA$346,761 · 1
By mechanism
R01$3,183,157 · 2
U10$2,090,373 · 1
K12$1,244,606 · 1
U01$519,012 · 1
M01$24,454 · 5
Top collaborators
- Duane A. Mitchell5 shared
Most similar at Children'S Research Institute
Same institution · by research overlap
- Terence A Partridge$2,629,382
- Ljubica Morizono Caldovic$2,687,852
- Nicholas Ah Mew$1,161,811
- Madison Mehalani Berl$1,982,436
- Lauren Kenworthy$8,071,804
Others in their field
Top investigators on “Child”
- Barbara Driver · Westat, Inc.$244,454,458
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$195,214,889
- George R Seage · Abt Associates, Inc.$189,009,744
- Carol Nesel · Westat$188,148,170
- Elizabeth A Thom · George Washington University$170,579,744
Research focus
ChildAreaResearch PersonnelGrantClinical ResearchNeurologicNeurologistNeurosciencesProgramsChildhoodAdultInstitutionResourcesClinical TrialsDesignMolecularEnsurePediatric HospitalsBaseNeuromuscular DiseasesNeuro-OncologyMemberEpilepsyCore Facility
Grant awards (33)
Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas$614,852
R01 · FY2019 · CA
Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas$633,869
R01 · FY2018 · CA
Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas$633,869
R01 · FY2017 · CA
Children's National Medical Center Application for NEXT$344,000
U10 · FY2017 · NS · contact PI
Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas$492,969
R01 · FY2016 · CA
Children's National Medical Center Application for NEXT$344,000
U10 · FY2016 · NS · contact PI
Neurological Sciences Academic Development at CNMC.$1
K12 · FY2016 · NS · contact PI
Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas$460,837
R01 · FY2015 · CA
Children's National Medical Center Application for NEXT$273,000
U10 · FY2015 · NS · contact PI
Neurological Sciences Academic Development at CNMC.$1
K12 · FY2015 · NS · contact PI
Children's National Medical Center Application for NEXT$287,000
U10 · FY2014 · NS · contact PI
Neurological Sciences Academic Development at CNMC.$154,278
K12 · FY2014 · NS · contact PI
Children's National Medical Center Application for NEXT$154,373
U10 · FY2013 · NS · contact PI
Neurological Sciences Academic Development at CNMC.$154,278
K12 · FY2013 · NS · contact PI
Children's National Medical Center Application for NEXT$344,000
U10 · FY2012 · NS · contact PI
Neurological Sciences Academic Development at CNMC.$154,278
K12 · FY2012 · NS · contact PI
Children's National Medical Center Application for NEXT$344,000
U10 · FY2011 · NS · contact PI
Neurological Sciences Academic Development at CNMC.$73,462
K12 · FY2010 · NS · contact PI
A RANDOMIZED PLACEBO-CONTROLLED STUDY OF LOVASTATIN (TM) IN CHILDREN WITH$5,383
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: A PHASE II STUDY OF THE MTOR INHIBITOR SIROLIMUS IN NEUROFIBROMA$4,893
M01 · FY2010 · RR · contact PI
A PHASE II STUDY OF THE MTOR INHIBITOR SIROLIMUS IN NEUROFIBROMATOSIS TYPE 1$4,376
M01 · FY2009 · RR · contact PI
Neurological Sciences Academic Development at CNMC$1
K12 · FY2009 · NS · contact PI
Neurological Sciences Academic Development at CNMC$303,631
K12 · FY2008 · NS · contact PI
Neurological Sciences Academic Development at CNMC$269,190
K12 · FY2007 · NS · contact PI
Pirfenidone in Children with PNs in NF1$346,761
R01 · FY2006 · FD · contact PI
Neurological Sciences Academic Development at CNMC.$135,486
K12 · FY2006 · NS · contact PI
PHASE I STUDY OF PERFENIDIONE IN NF1 AND PLEXIFORM NEUROFIBROMAS$1,033
M01 · FY2006 · RR · contact PI
Pirfenidone in Children with PNs in NF1$0
R01 · FY2005 · FD
Phase I Study of Perfenidione in NF1 and Plexiform Neurofibromas$8,769
M01 · FY2004 · RR
CHILDRENS NATIONAL MEDICAL CENTER$131,404
U01 · FY2003 · CA
CHILDRENS NATIONAL MEDICAL CENTER$127,133
U01 · FY2002 · CA
CHILDRENS NATIONAL MEDICAL CENTER$131,889
U01 · FY2001 · CA
CHILDRENS NATIONAL MEDICAL CENTER$128,586
U01 · FY2000 · CA